Information about Immopharma
My details
*
*
*

Company information

Status
Active

Enterprise number

BE0427.622.025

VAT liability
Yes
Established
22-11-1984
Last balance sheet year
2024
Company size
Micro 0 FTE
Principal activity
Rental and operating of own or leased real estate, except land
Health barometer
Credit limit
Detailpage

Are you looking for more information about this company?

  • Consult health at a glance

  • Choose quick insights or granular details

  • Get updates on important developments

7-day free trial, no credit card required.

Financial data from Immopharma

2024 2023 2022 2021
Profit/Loss -10,643 43 % -18,831 -30 % -14,450 -99 % -7,268
Equity 220,596 -5 % 231,239 -8 % 250,069 -5 % 264,519
Gross margin -395 95 % -7,621 -12 % -6,788 -181 % 8,377

Publications from Immopharma

Date Publication
12-04-2024 Resignations - Appointments (NL)
29-12-2022 Articles of Association (Translation, Coordination, Other Modifications, …) - Goal - Capital - Shares - Resignations - Appointments (NL)
22-01-2018 Capital - Shares (NL)
18-03-2013 Registered Office (NL)
03-05-2012 Resignations - Appointments (NL)

Frequently asked questions

What is the VAT number of Immopharma?
The VAT number of Immopharma is BE 0427.622.025.
Wat is the PEPPOL ID of Immopharma?
There is no information available about the PEPPOL ID of Immopharma or the company is not yet registered on the PEPPOL network.
When was Immopharma founded?
Immopharma was founded on 22-11-1984.
What is the address of Immopharma?
The current registered office of Immopharma is located at Sint-Annastraat 4, 9420 Erpe-Mere.
When was the last time Immopharma filed their annual financial statements?
The most recent financial statements of Immopharma were filed on 08-04-2025.
How many employees does Immopharma have?
There are currently no employees working at Immopharma or no workforce information is available.
What is the annual turnover of Immopharma?
At the time of its most recent financial statements, Immopharma did not publish any turnover figures. Immopharma reported a gross margin of -€395.06.